MX2011007232A - Derivados de benzotiazolona. - Google Patents

Derivados de benzotiazolona.

Info

Publication number
MX2011007232A
MX2011007232A MX2011007232A MX2011007232A MX2011007232A MX 2011007232 A MX2011007232 A MX 2011007232A MX 2011007232 A MX2011007232 A MX 2011007232A MX 2011007232 A MX2011007232 A MX 2011007232A MX 2011007232 A MX2011007232 A MX 2011007232A
Authority
MX
Mexico
Prior art keywords
benzothiazolone derivative
benzothiazolone
derivative
inhibitors
compounds
Prior art date
Application number
MX2011007232A
Other languages
English (en)
Inventor
Dieter Dorsch
Oliver Schadt
Frank Stieber
Andree Blaukat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MX2011007232A publication Critical patent/MX2011007232A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Los compuestos de la fórmula I (ver fórmula (I)) en donde R1, R2, R3, R3', R4, R4', E, E' , E'' y E''' tienen los significados indicados en la reivindicación 1, son inhibidores de las tirosina cinasas, en especial de la Met-cinasa, y pueden utilizarse, por ejemplo, para el tratamiento de tumores.
MX2011007232A 2009-01-07 2009-12-08 Derivados de benzotiazolona. MX2011007232A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009003975A DE102009003975A1 (de) 2009-01-07 2009-01-07 Benzothiazolonderivate
PCT/EP2009/008756 WO2010078905A1 (de) 2009-01-07 2009-12-08 Benzothiazolonderivate

Publications (1)

Publication Number Publication Date
MX2011007232A true MX2011007232A (es) 2011-08-03

Family

ID=41600341

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007232A MX2011007232A (es) 2009-01-07 2009-12-08 Derivados de benzotiazolona.

Country Status (16)

Country Link
US (1) US8877751B2 (es)
EP (1) EP2373635A1 (es)
JP (1) JP5653933B2 (es)
KR (1) KR20110102504A (es)
CN (1) CN102272112A (es)
AR (1) AR074989A1 (es)
AU (1) AU2009336847B2 (es)
BR (1) BRPI0923602A2 (es)
CA (1) CA2748908C (es)
DE (1) DE102009003975A1 (es)
EA (1) EA021067B1 (es)
IL (1) IL213827A (es)
MX (1) MX2011007232A (es)
SG (1) SG172424A1 (es)
WO (1) WO2010078905A1 (es)
ZA (1) ZA201105779B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014132205A1 (en) * 2013-02-28 2014-09-04 Novartis Ag Formulation comprising benzothiazolone compound
EP2933245A1 (en) * 2014-04-17 2015-10-21 Bayer Technology Services GmbH Oxidative carbonylation of amino aryl compounds by aryl formates
WO2017108569A1 (en) 2015-12-22 2017-06-29 Syngenta Participations Ag Pesticidally active pyrazole derivatives
KR102660608B1 (ko) * 2019-02-01 2024-04-26 지앙수 아오사이캉 파마수티칼 씨오., 엘티디. c-Met억제제로서 피리미디닐기를 포함하는 삼환식 화합물
CN115583939A (zh) * 2022-11-04 2023-01-10 苏州莱安医药化学技术有限公司 一种特泊替尼中间体的合成方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
CA2242425C (en) 1996-02-13 2006-07-18 Zeneca Limited Quinazoline derivatives as vegf inhibitors
NZ331191A (en) 1996-03-05 2000-03-27 Zeneca Ltd 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
BR0111230A (pt) 2000-05-31 2003-06-10 Astrazeneca Ab Composto, e, uso e processo para a preparação do mesmo
KR20030014425A (ko) 2000-07-07 2003-02-17 앤지오젠 파마슈티칼스 리미티드 혈관 손상제인 콜치놀 유도체
EE200300015A (et) 2000-07-07 2004-10-15 Angiogene Pharmaceuticals Limited Kolhinooli derivaadid kui angiogeneesi inhibiitorid
WO2002096361A2 (en) 2001-05-30 2002-12-05 Sugen, Inc. 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
CA2454538A1 (en) 2001-06-22 2003-01-03 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
MXPA04003668A (es) 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
EP1492487B1 (en) 2002-03-08 2009-11-11 Merck & Co., Inc. Mitotic kinesin inhibitors
JP2007516180A (ja) 2003-07-02 2007-06-21 スゲン，インコーポレイティド ｃ−Ｍｅｔ阻害薬としてのアリールメチルトリアゾロおよびイミダゾピラジン類
EP2210607B1 (en) 2003-09-26 2011-08-17 Exelixis Inc. N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer
CA2572331A1 (en) 2004-07-02 2006-02-09 Exelixis, Inc. C-met modulators and method of use
DE102004036581A1 (de) 2004-07-28 2006-03-23 Robert Bosch Gmbh Verfahren zum Betreiben eines Hybridantriebs und Vorrichtung zur Durchführung des Verfahrens
CH697191A5 (de) 2004-07-29 2008-06-25 Biospectra Ag Mehrfach-Bioreaktorvorrichtung.
EP1621785A1 (en) 2004-07-30 2006-02-01 Mecos Traxler AG Method and apparatus for controlling a magnetic bearing device
CA2577937C (en) 2004-08-26 2010-12-21 Pfizer Inc. Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
US7642275B2 (en) 2004-12-16 2010-01-05 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP2008533122A (ja) 2005-03-18 2008-08-21 オーキッド ケミカルズ アンド ファーマシューティカルズ リミテッド 新規なチロシン誘導体
DE102005038537A1 (de) 2005-08-16 2007-02-22 Merck Patent Gmbh 1-Acyldihydropyrazolderivate
DE102005055354A1 (de) 2005-11-21 2007-10-31 Merck Patent Gmbh Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine
DE102007026341A1 (de) * 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate

Also Published As

Publication number Publication date
US8877751B2 (en) 2014-11-04
IL213827A (en) 2015-05-31
ZA201105779B (en) 2012-04-25
EA201101042A1 (ru) 2012-01-30
IL213827A0 (en) 2011-07-31
JP2012514610A (ja) 2012-06-28
CN102272112A (zh) 2011-12-07
BRPI0923602A2 (pt) 2016-01-12
EA021067B1 (ru) 2015-03-31
WO2010078905A1 (de) 2010-07-15
AR074989A1 (es) 2011-03-02
AU2009336847A1 (en) 2011-08-25
CA2748908C (en) 2017-10-24
US20110269756A1 (en) 2011-11-03
DE102009003975A1 (de) 2010-07-08
JP5653933B2 (ja) 2015-01-14
KR20110102504A (ko) 2011-09-16
CA2748908A1 (en) 2010-07-15
EP2373635A1 (de) 2011-10-12
AU2009336847B2 (en) 2015-12-10
SG172424A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
MY155719A (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
MX2009013077A (es) Derivados dde benzoxazolona.
MX2009012708A (es) Derivados de piridazinona.
MY153727A (en) Pyridazinone derivatives
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
EA201100966A1 (ru) Производные пиридазинона
MX2009012709A (es) Derivados de arileter-piridazinona.
MX2010003366A (es) Derivados de piperidina y piperazina para el tratamiento de tumores.
MX2011007165A (es) Derivados de piridazinona.
EA201001648A1 (ru) Производные пиридазинона
EP2170337A4 (en) NEW TRIAZOLOPYRIDAZINE
EA201200653A1 (ru) Гетариламинохинолины
WO2008017361A3 (de) 2-(heterocyclylbenzyl)-pyridazinonderivate
MX2012000709A (es) Inhibidores de pirrolopiridina de cinasas.
MX2014002683A (es) Derivados de benzonitrilo como inhibidores de cinasa.
MX2010003365A (es) Derivados de tiazol para el tratamiento de cancer.
EA201000004A1 (ru) Производные 6-(пирролопиридинил)пиримидин-2-иламина и их применение для лечения злокачественного новообразования и спида
EA201100334A1 (ru) Бициклические производные триазола для лечения опухолей
EA201100035A1 (ru) Производные тиазолилпиперидина
MX2010003563A (es) Inhibidores de proteina cinasa de c-met.
MX2011012524A (es) Inhibidores de proteina cinasa c-met.
MX2011012522A (es) Inhibidores de pirazol sustituido de proteina cinasa c-met.
MX2009009916A (es) Tetrahidroquinolinas sustituidas.
EA201101042A1 (ru) Производные бензотиазолона
UA106628C2 (uk) Метилпіролопіримідинкарбоксаміди

Legal Events

Date Code Title Description
FA Abandonment or withdrawal